Langley Porter Psychiatric Institute

Active Projects: 11

Project Investigator All Organizations Start date End date
Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients Derek D. Satre, PhD Langley Porter Psychiatric Institute
Psychology and Medicine: An integrative research approach Nancy Adler, PhD Langley Porter Psychiatric Institute
Pediatric Developmental Therapeutics Center of Excellence at UCSF Katherine K. Matthay, MD Langley Porter Psychiatric Institute
BADM CCC and UCSF Partnership Exploring the Brain Basis of Childhood Creativity Fumiko Hoeft, MD, PhD Langley Porter Psychiatric Institute
Measuring combined tobacco, e-cigarette, and marijuana use in California Danielle Ramo, PhD Langley Porter Psychiatric Institute
Reducing Duration of Untreated Psychosis through Rapid Identification and Engagement Rachel Loewy, PhD Langley Porter Psychiatric Institute
Study to Evaluate the Efficacy, Safety and Tolerability of Desvenlafaxine Succinate Sustained-Release (DVS SR) in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder Robert L. Hendren, DO Langley Porter Psychiatric Institute
A 6-Month Extension Study to B2061032 to Evaluate Desvenlafaxine Succinate Sustained-Release (DVS SR) Tablets in the Treatment of Children and Adolescent Outpatients with MDD Robert L. Hendren, DO Langley Porter Psychiatric Institute
A Randomized, Double-blind, Multicenter, Placebo-controlled, Parallel-group, Efficacy and Safety Study of 2 Doses of Dasotraline in Adults with Attention Deficit Hyperactivity Disorder (ADHD) R. Keith McBurnett, PhD Langley Porter Psychiatric Institute
Understanding literacy acquisition through immersion in foreign languages Fumiko Hoeft, MD, PhD Global Health Sciences Faculty Affiliate, Langley Porter Psychiatric Institute
Joint Personnel Agreement - Thomas C. Neylan Thomas Neylan, MD Global Health Sciences Faculty Affiliate, Langley Porter Psychiatric Institute

Archived Projects: 82

Project Investigator All Organizations Start date End date
Sensitivity of Electronic Alcohol Diagnosis Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Safety of a Nicotine Reduction Strategy Neal L. Benowitz, MD Langley Porter Psychiatric Institute
Child-Parent Intervention with Marital Violence Sequelae Alicia F. Lieberman, PhD Langley Porter Psychiatric Institute
Sarlo Prize for An Outstanding Professor in the Department of Psychiatry Craig Van Dyke, MD Langley Porter Psychiatric Institute
Twelve-Week Study Evaluating the Safety and Efficacy of Varenicline Tartrate ( CP-526,555) in Comparison to Zyban for Smoking Cessation Victor I. Reus, MD Langley Porter Psychiatric Institute
Neuroscience Research of Nicotine and Nicotine Abuse Neal L. Benowitz, MD Langley Porter Psychiatric Institute
Impact of Services on Problem Drinking Trajectories Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Policy Implications of Different Treatment Approaches for Individuals with Co-Occurring Substance Abuse and Mental Health Disorders Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Training Next Generation Mental Health Researchers Victor I. Reus, MD Langley Porter Psychiatric Institute
Integrated Drug and Medical Care - Cost and Effectiveness Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Outcome and Cost of Day Hospital vs. Outpatient Care Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Cognitive Strategies for Improving Outcome Measurement Martha Shumway, PhD Langley Porter Psychiatric Institute
Admixture Mapping Schizophrenia Genes in Oceanic Palau William F. Byerley, MD Langley Porter Psychiatric Institute
Family Members of Alcohol Patients Utilization and Cost Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Course of Problems in Adolescent Drug Treatment Intakes Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Phase 2, Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study to Assess Safety and Immunogenicity of Two Doses of 3?-aminomethylnicotine-P. aeruginosa r Exoprotein A Conjugate Vaccine (NicVAX?) in 2 Different Dosing Schedules in Smokers Victor I. Reus, MD Langley Porter Psychiatric Institute
A Stage-Based Scheduled Smoking Intervention for Chinese Janice Y. Tsoh, PhD Langley Porter Psychiatric Institute
Continuing Care for Substance Use Problems: Primary Care, Mental Health, and Chemical Dependency Services Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Long-Term Impact of Drug Treatment on Outcome and Cost Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Gender Differences in Problem Drinking Trajectories Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Improving Alcohol and Drug Services for Older Adults Derek D. Satre, PhD Langley Porter Psychiatric Institute
An Affected SibPair Study of Attention Deficit Hyperactivity Disorder (ADHD) in Costa Rica Carol A. Mathews, MD Langley Porter Psychiatric Institute
Screening for Youth Alcohol and Drug Use: A Study of Primary Care Providers Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Population Genetic Mapping of Tourette Syndrome Victor I. Reus, MD Langley Porter Psychiatric Institute
Genetics of Schizophrenia in Oceanic Palau William F. Byerley, MD Langley Porter Psychiatric Institute
Training Next Generation Mental Health Researchers Victor I. Reus, MD Langley Porter Psychiatric Institute
Bipolar Endophenotypes in Population Isolates Victor I. Reus, MD Langley Porter Psychiatric Institute
Life-Course and Cost Trajectories of Alcohol Patients: a 15-Year Study Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
A Genetic Linkage Study of GTS Carol A. Mathews, MD Langley Porter Psychiatric Institute
Identifying Intermediate Phenotypes for Compulsive Hoarding Carol A. Mathews, MD Langley Porter Psychiatric Institute
Integrated Drug and Medical Care-Cost and Effectiveness Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Predictors & Outcomes of Cognitive Trajectories in the Oldest of Old Kristine Yaffe, MD Langley Porter Psychiatric Institute
Predoctoral Training Consortium in Affective Science Margaret E. Kemeny, PhD Langley Porter Psychiatric Institute
A Family Intervention to Reduce Smoking in Vietnamese Men Janice Y. Tsoh, PhD Langley Porter Psychiatric Institute
Whole Genome Sequencing of Multiplex Schizophrenia Pedigrees from an Isolated Population William F. Byerley, MD Langley Porter Psychiatric Institute
High Deductible Health Plans: Substance Abuse Service Use and Cost Trajectories Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
A Genetic Linkage Study of Gilles de la Tourette Syndrome Carol A. Mathews, MD Langley Porter Psychiatric Institute
The Chinese Community Internet Stop Smoking Project Janice Y. Tsoh, PhD Langley Porter Psychiatric Institute
Assessing the Validity of a Web-Based Phenotyping Tool for Tourette Syndrome Carol A. Mathews, MD Langley Porter Psychiatric Institute
Autism and the RASopathies Lauren A. Weiss, PhD Langley Porter Psychiatric Institute
Partnership for Contraceptive Decision Support Christine E. Dehlendorf, MD, MAS Bixby Center for Global Reproductive Health, Langley Porter Psychiatric Institute
Study Evaluating the Safety and Efficacy of Fixed-Dose Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder R. Keith McBurnett, PhD Langley Porter Psychiatric Institute
An Open-Label, Multicenter Study Evaluating the Safety and Tolerability of Once-Daily Oral Aripiprazole in Children and Adolescents with Tourette's Disorder R. Keith McBurnett, PhD Langley Porter Psychiatric Institute
Pilot Test of a Contraceptive Decision Support Tool Christine E. Dehlendorf, MD, MAS Langley Porter Psychiatric Institute
A Phase 4, Randomized, Double-Blind, Multicenter, Parallel-Group, Active-Controlled, Forced-Dose Titration, Safety and Efficacy Study of SPD489 (VYVANSE®) Compared with OROS-MPH (CONCERTA®) with a Placebo Reference Arm, in Adolescents Aged 13-17 Year R. Keith McBurnett, PhD Langley Porter Psychiatric Institute
Phase 4, Parallel Group, Active-Controlled, Dose-Optimization Study of SPD489 (Vyvanse) Compared with OROS-MPH (Concerta) with a Placebo Reference Arm, in Adolescents 13-17 with Attention-deficit/Hyperactivity Disorder R. Keith McBurnett, PhD Langley Porter Psychiatric Institute
The Impact of Health Care Reform on Addiction and HIV Services Derek D. Satre, PhD Langley Porter Psychiatric Institute
Alameda MHSA-Early Intervention at Onset of First Psychosis Rachel Loewy, PhD Langley Porter Psychiatric Institute
Dialectical Behavior Therapy (DBT) for At-Risk Adolescents Training Langley Porter Psychiatric Institute
Comparison of Brain Activation Patterns in Hoarding Disorder and Non-Hoarding Obsessive Cumpulsive Disorder (OCD) Carol A. Mathews, MD Langley Porter Psychiatric Institute
Motivational Interviewing to Reduce Substance Use Among Depression Patients Derek D. Satre, PhD Langley Porter Psychiatric Institute
Alcohol SBIRT Implementation in an HMO: Non-Physician Providers vs. Physicians Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Predictors of MCI/Dementia among the Oldest Old Women Kristine Yaffe, MD Langley Porter Psychiatric Institute
Neuroscience-Guided Cognitive Remediation in Adolescents at Risk for Psychosis Rachel Loewy, PhD Langley Porter Psychiatric Institute
Trauma and stress responsivity in youth at ultra-high-risk for psychosis Rachel Loewy, PhD Langley Porter Psychiatric Institute
Prenatal and Neonatal Biomarkers for Autism Lauren A. Weiss, PhD Langley Porter Psychiatric Institute
Developing a Smokefree Intervention for Chinese Smokers and Nonsmokers Janice Y. Tsoh, PhD Langley Porter Psychiatric Institute
An Open-Label Extension of the Safety and Tolerability of Memantine in Pediatric Patients with Autism, Asperger Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Robert L. Hendren, DO Langley Porter Psychiatric Institute
Practice-based Intervention for Vietnamese & Korean Patients Janice Y. Tsoh, PhD Langley Porter Psychiatric Institute
Memantine in Pediatric Patients with Autism, Asperger Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Robert L. Hendren, DO Langley Porter Psychiatric Institute
Study of the Safety and Tolerability of Memantine in Pediatric Patients with Autism, Asperger Disorder or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) Robert L. Hendren, DO Langley Porter Psychiatric Institute
Family Members of Alcohol Patients: Utilization and Cost Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Center for Advancing Longitudinal Drug Abuse Research Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Dissecting Epistasis and Pleiotropy in Autism Towards Personalized Medicine Lauren A. Weiss, PhD Langley Porter Psychiatric Institute
Biomarkers for PTSD in Female Iraq and Afghanistan Veterans Owen Wolkowitz, MD Langley Porter Psychiatric Institute
An Open-Label Extension Study of LUMINENZ-AT™ Robert L. Hendren, DO Langley Porter Psychiatric Institute
Refining the Tourette Syndrome Phenotype Across Diagnoses to Aid Gene Discovery Carol A. Mathews, MD Langley Porter Psychiatric Institute
CBT-I for Bipolar Disorder Thomas Neylan, MD Global Health Sciences Faculty Affiliate, Langley Porter Psychiatric Institute
Allostatic Load, Genetics and Neurobiology in PTSD: Identifying Novel Biomarkers of Combat-Related Post-Traumatic Stress Disorder (PTSD) Owen Wolkowitz, MD Langley Porter Psychiatric Institute
Improving PTSD Outcomes in OIF/OEF Returnees: A Randomized Clinical Trial of Hydrocortisone Augmentation of Prolonged Exposure Therapy - Additional Biomarkers Owen Wolkowitz, MD Langley Porter Psychiatric Institute
Cell Aging in Major Depression Owen Wolkowitz, MD Langley Porter Psychiatric Institute
Membrane Trafficking of Vesicular Neurotransmitter Transporters Susan Voglmaier, MD, PhD Langley Porter Psychiatric Institute
Neurological predictors of spoken and written language learning Fumiko Hoeft, MD, PhD Global Health Sciences Faculty Affiliate, Langley Porter Psychiatric Institute
The nature and acquisition of the speech code and reading Fumiko Hoeft, MD, PhD Global Health Sciences Faculty Affiliate, Langley Porter Psychiatric Institute
Treatment for Complex Patients: Continuing and Extended Care Joseph R. Guydish, PhD Langley Porter Psychiatric Institute
Screening for Youth Alcohol and Drug Use: A Study of Primary Care Providers Constance M. Weisner, DrPH Langley Porter Psychiatric Institute
Training Next Generation Mental Health Researchers Carol A. Mathews, MD Langley Porter Psychiatric Institute
131I-MIBG Imaging and Therapy for Neuroblastoma: Infrastructure Proposal Katherine K. Matthay, MD Langley Porter Psychiatric Institute
Dialectical Behavior Therapy (DBT) Training Services for Contra Costa County Mental Health Services Langley Porter Psychiatric Institute
Variation in Neuroligin Concentration and Presynaptic Functional Development Susan Voglmaier, MD, PhD Langley Porter Psychiatric Institute
Comparison of Peer Facilitated Support Group and Cognitive Behavioral Therapy for Hoarding Disorder Carol A. Mathews, MD Langley Porter Psychiatric Institute
Accelerated Biological Aging in Schizophrenia Owen Wolkowitz, MD Langley Porter Psychiatric Institute